Table 2.
Changes in serum CRP levels after one week’s treatment using NSAIDs in patients with PMR, pseudogout, RS3PE syndrome, and post-infectious polyarthritis
| Case | Diagnosis | CRP (mg/dl) | %Changes of serum CRP levels | |
|---|---|---|---|---|
| PMR (n = 7) | Before | 10.4 ± 4.4 | −7.2% | |
| After one week | 9.1 ± 3.4# | |||
| A | Pseudogout | Before | 24.3 | −95.1% |
| After one week | 1.2 | |||
| B | RS3PE syndrome | Before | 20.8 | −22.1% |
| After one week | 16.2 | |||
| C | Post-infectious polyarthritis | Before | 12.1 | −89.3% |
| After one week | 1.3 |
Notes: Case A–C corresponds to A–C in Figure 1, respectively. Values in PMR patients indicate mean ± SD.
#
Indicates no significant differences vs values before treatment by Wilcoxon’s signed rank test.
Abbreviations: CRP, C-reactive protein; MMP-3, matrix metalloproteinase-3; PMR, polymya rheumatica; RS3PE, remitting seronegative symmetrical synovitis with pitting edema.